Laurus Labs shares tank 10% on Thursday's trade. The company reported another flow show in Q3. Brokerage firms remain bearish, cut target prices. Shares of Laurus Labs Ltd hit a lower circuit during ...

When Dr Satyanarayana Chava started Laurus Labs in 2007, he invested nearly Rs 60 crore of his own money into it. His confidence in its success was neither bravado nor bluster, but defined by his ...

Laurus Labs has seen a notable increase in its consensus analyst price target, which has risen from ₹724.14 to ₹815.86. This revision follows renewed analyst optimism, attributed largely to the ...

Revenue: INR1,570 crores, reflecting a 31% year-on-year growth. Gross Margin: 59%, an increase of more than 4% due to better product mix and process improvements. EBITDA: INR389 crores with a margin ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Hyderabad: Laurus Bio, a subsidiary of Hyderabad-based biopharma player Laurus Labs Ltd, has secured an equity investment of Rs 120 crore from Eight Roads Ventures and F-Prime Capital. Laurus Labs ...

Sharekhan had an interaction with Laurus Labs management and their commentary was positive, pointing towards a robust growth outlook. Laurus’ formulations business is on a strong growth footing, ...

Laurus Labs share price opened at an intraday low of ₹358.70 apiece on BSE. (AP Photo/Lo Sai Hung) According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One, Laurus Labs stock ...

2 Annual General Meeting / Dividend- Rs 1.50 Per Share 28-Jun-18- 2 Annual General Meeting/Dividend - Rs 1.50/- Per Share 06-Jul-17- Catch latest stock market updates here. For all other news related ...

Laurus has emerged as a dominant, independent API provider in the anti-retro viral (ARV) segment, which accounts for 70% of its revenues and where it has a complete portfolio. (Reuters) We initiate ...